MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Price, Quote, News and Overview
NASDAQ:MRVI - Nasdaq - US56600D1072 - Common Stock - Currency: USD
MRVI Quote, Performance and Key Statistics
MARAVAI LIFESCIENCES HLDGS-A
NASDAQ:MRVI (2/10/2025, 8:13:25 PM)
After market: 4.58 +0.28 (+6.51%)4.3
-0.28 (-6.11%)
The current stock price of MRVI is 4.3 USD. In the past month the price decreased by -11.34%. In the past year, price decreased by -19.02%.
MRVI Latest News and Analysis
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Announces Earnings Release Date
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Announces Earnings Release Date...
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman
MRVI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.29 | 211.47B | ||
| DHR | DANAHER CORP | 27.17 | 146.98B | ||
| A | AGILENT TECHNOLOGIES INC | 27.16 | 40.98B | ||
| IQV | IQVIA HOLDINGS INC | 18.58 | 37.57B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 32.57 | 28.28B | ||
| WAT | WATERS CORP | 35.78 | 24.20B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 47.95 | 23.47B | ||
| ILMN | ILLUMINA INC | 42.85 | 16.65B | ||
| ICLR | ICON PLC | 13.6 | 15.76B | ||
| RVTY | REVVITY INC | 23.44 | 13.98B | ||
| AVTR | AVANTOR INC | 19.01 | 12.94B | ||
| TECH | BIO-TECHNE CORP | 38.63 | 11.11B |
Related stock screener links
About MRVI
Company Profile
Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 580 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The firm operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.
Company Info
MARAVAI LIFESCIENCES HLDGS-A
10770 Wateridge Circle Suite 200, Suite 200
San Diego CALIFORNIA 92121 US
CEO: Carl Hull
Employees: 580
Company Website: https://www.maravai.com/
Investor Relations: https://investors.maravai.com/
Phone: 18585460004
MRVI FAQ
What is the stock price of MRVI?
The current stock price of MRVI is 4.3 USD.
What is the symbol for MARAVAI LIFESCIENCES HLDGS-A stock?
The exchange symbol of MARAVAI LIFESCIENCES HLDGS-A is MRVI and it is listed on the Nasdaq exchange.
On which exchange is MRVI stock listed?
MRVI stock is listed on the Nasdaq exchange.
Is MRVI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MRVI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MRVI.
Does MRVI stock pay dividends?
MRVI does not pay a dividend.
When does MRVI stock report earnings?
MRVI will report earnings on 2025-02-25, after the market close.
What is the Price/Earnings (PE) ratio of MRVI?
MRVI does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
What is the Short Interest ratio of MRVI stock?
The outstanding short interest for MRVI is 7.46% of its float.
MRVI Technical Analysis
MRVI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MRVI. MRVI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MRVI Financial Highlights
Over the last trailing twelve months MRVI reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -108.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.58% | ||
| ROE | -65.09% | ||
| Debt/Equity | 1.59 |
MRVI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to MRVI. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -369.72% and a revenue growth -6.88% for MRVI